Architectural transcription factor HMGI(Y) promotes tumor progression and mesenchymal transition of human epithelial cells

Molecular and Cellular Biology

Volumn 21, Issue 2, 2001, Pages 575-594

  Reeves, R ^a   Edberg, D D ^a   Li, Y ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTEGRIN; TRANSCRIPTION FACTOR; TRANSCRIPTION FACTOR HMGI; UNCLASSIFIED DRUG;

ANCHORAGE INDEPENDENT GROWTH; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; BREAST EPITHELIUM; CELL PROLIFERATION; CELL STRAIN MCF 7; CONTROLLED STUDY; FEMALE; HELA CELL; HUMAN; HUMAN CELL; IMMUNOHISTOCHEMISTRY; MALIGNANT TRANSFORMATION; METASTASIS POTENTIAL; MOUSE; NONHUMAN; NUDE MOUSE; PRIORITY JOURNAL; TRANSCRIPTION REGULATION;

ANIMALS; BREAST NEOPLASMS; CELL ADHESION; CELL DIVISION; CELL TRANSFORMATION, NEOPLASTIC; DISEASE PROGRESSION; EPITHELIAL CELLS; FEMALE; GENE EXPRESSION PROFILING; GENE EXPRESSION REGULATION, NEOPLASTIC; HIGH MOBILITY GROUP PROTEINS; HMGA1A PROTEIN; HUMANS; INTEGRINS; MESODERM; MICE; MICE, INBRED BALB C; MICE, NUDE; NEOPLASM METASTASIS; NEOPLASM PROTEINS; NEOPLASM TRANSPLANTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PROTEIN ISOFORMS; RNA, MESSENGER; SIGNAL TRANSDUCTION; TRANSCRIPTION FACTORS; TUMOR CELLS, CULTURED;

EID: 0035164289     PISSN: 02707306     EISSN: None     Source Type: Journal    
DOI: 10.1128/MCB.21.2.575-594.2001     Document Type: Article

References (136)

1. Determination of high mobility group I(Y) expression level in colorectal neoplasias: A potential diagnostic marker
2. Distinct types of diffuse large B-cell lymphoma identified by gene expression profiling
3. Expression of HMGI(Y) proteins in squamous intraepithelial and invasive lesions of the uterine cervix
4. Differential in vivo modifications of the HMGI(Y) nonhistone chromatin proteins modulate nucleosome and DNA interactions
5. Circulating intercellular adhesion molecule-1(ICAM-1), E-selectin and vascular cell adhesion molecule-1 (VCAM-1) in human malignancies
6. Mini-mouse phenotypic characterization of a transgenic insertional mutant allelic to "pygmy"
7. Inhibition of HMG-IC protein synthesis suppresses retrovirally induced neoplastic transformation of rat thyroid cells
8. Epithelialmesenchymal transitions in cancer progression
9. Epithelial differentiation and the control of metastasis in carcinomas
10. Extracellular matrix signaling: Integration of form and function in normal and malignant cells
11. Vascular stroma formation in carcinoma in situ, invasive carcinoma, and metastatic carcinoma of the breast
12. Identification of high mobility group protien I(Y) as potential progression marker for prostate cancer by differential hybridization analysis
13. High-mobility-group chromosomal proteins: Architectural components that facilitate chromatin function
14. The gene for the human architectural transcription factor HMGI-C consists of five exons each coding for a distinct functional element
15. Stable interaction between the products of the BRCA1 and BRCA2 tumor suppressor genes in mitotic and meiotic cells
16. High level expression of the HMGI(Y) gene during embryonic development
17. Detection of high mobility group I HMGI(Y) protein in the diagnosis of thyroid tumors: HMGI(Y) expression represents a potential diagnostic indicator of carcinoma
18. Enhancement of serum-response factor-dependent transcription and DNA binding by the architectural transcription factor HMG-I(Y)
19. Integrins and signal transduction pathways: The road taken
20. Genomic analysis of metastasis reveals an essential role for RhoC
21. Tumor promoter induces high mobility group HMG-Y protein ex pression in transformation-sensitive but not -resistant cells
22. The alpha 6 beta 1 and alpha 6 beta 4 integrins in human prostate cancer progression
23. Functional interaction between the DNA binding domain of NF-Y and the high mobility group protein HMG-I(Y)
24. Integrin-linked kinase (ILK): A regulator of integrin and growth-factor signalling
25. Phosphoinositide-3-OH kinase-dependent regulation of glycogen synthase kinase 3 and protein kinase B/AKT by the integrin-linked kinase
26. Is plasminogen activator inhibitor-1 the molecular switch that governs urokinase receptor-mediated cell adhesion and release?
27. Vimentin is preferentially expressed in human breast carcinomas with low estrogen receptor and high Ki-67 growth fraction
28. Vimentin is preferentially expressed in high-grade ductal and medullary, but not in lobular breast carcinomas
29. Use of tetracycline operator system to regulate oncogene expression in mammalian cells
30. Membrane associated matrix metalloproteinases in metastasis
31. A matter of life and cell death
32. Reversal of intrinsic DNA bends in the IFN beta gene enhancer by transcription factors and the architectural protein HMG I(Y)
33. Diverse signaling pathways activated by growth factor receptors induce broadly overlapping, rather than independent, sets of genes
34. A poly(dA-dT) upstream activating sequence binds high-mobility group I protein and contributes to lymphotoxin (tumor necrosis factor-β) gene regulation
35. Genetic analyses of integrin function in mice
36. Truncated and chimeric HMGI-C genes induce neoplastic transformation of NIH3T3 murine fibroblasts
37. Organization, inducible-expression and chromosome localization of the human HMG-I(Y) nonhistone protein gene
38. Changes in nuclear proteins on transformation of rat epithelial thyroid cells by murine sarcoma retrovirus
39. Integrin signaling
40. Comparison of multiple forms of high mobility group proteins in rodent and human cells. Identification of the human high mobility group I-C protein
41. Analysis of the HMGI nuclear proteins in mouse neoplastic cells induced by different procedures
42. Elevated levels of a specific class of nuclear phosphoproteins in cells transformed with v-ras and v-mos oncogenes and by co-transfection with c-myc and polyoma middle T antigens
43. Induction of cell scattering by expression of beta1 integrins in beta1-deficient epithelial cells requires activation of members of the rho family of GTPases and dowaregulation of cadherin and catenin function
44. Two syngenic cell lines from human breast tissue: The aneuploid mammary epithelial (Hs578T) and the diploid myoepithelial (Hs578Bst) cell lines
45. Rho GTPases and the actin cytoskeleton
46. The hallmarks of cancer
47. Protein kinase mediators of integrin signal transduction
48. Regulation of cell adhesion and anchorage-dependent growth by a new beta 1-integrin-linked protein kinase
49. An overview of epithelio-mesenchymal transformation
50. Identification of c-MYC as a target of the APC pathway
51. Expression of most matrix metalloproteinase family members in breast cancer represents a tumor-induced host response
52. Chromosomal translocations in benign tumors
53. Directional binding of HMG-I(Y) on four-way junction DNA and the molecular basis for competitive binding with HMG-1 and histone H1
54. Competition between HMG-I(Y), HMG-1 and histone H1 on four-way junction DNA
55. High mobility group protein I(Y) is required for function and for c-Rel binding to CD28 response elements within the GM-CSF and IL-2 promoters
56. The role of high-mobility group I(Y) proteins in expression of IL-2 and T cell proliferation
57. Effects of epidermal growth factor and estrogen on the regulation of the HMG-I/Y gene in human mammary epithelial cell lines
58. Oncoprotein networks
59. The solution structure of an HMG-(Y)-DNA complex defines a new architectural minor groove binding motif
60. Integrins: Versatility, modulation, and signaling in cell adhesion
61. The transcriptional program in the response of human fibroblasts to serum
62. Urokinase (uPA) and its inhibitor PAI-1 are strong and independent prognostic factors in node-negative breast cancer
63. Regulation of cell-type-specific interleukin-2 receptor α-chain gene expression: Potential role of physical interactions between Elf-1, HMG-I(Y), and NF-κB family proteins
64. Expression of mRNAs encoding mammalian chromosomal proteins HMG-I and HMG-Y during cellular proliferation
65. Complete murine cDNA sequence, genomic structure, and tissue expression of the high mobility group protein HMG-I(Y)
66. Alternative processing of mRNAs encoding mammalian chromosomal high-mobility-group proteins HMG-I and HMG-Y
67. Separation of human epidermal stem cells from transit amplifying cells on the basis of differences in integrin function and expression
68. Aggressive breast cancer leads to discrepant serum levels of the type I procollagen propeptides PINP and PICP
69. Focal adhesion kinase and its potential involvement in tumor invasion and metastasis
70. Signaling by integrin receptors
71. Growth factor-induced delayed early response genes
72. A conformational study of the sequence specific binding of HMG-I(Y) with the bovine interleukin-2 cDNA
73. MCF-7: The first hormone-responsive breast cancer cell line
74. Cooperativity between two NF-κB complexes, mediated by high-mobility-group protein I(Y), is essential for cytokine-induced expression of the E-selectin promoter
75. Genomic structure and expression of the murine Hmgi(y) gene
76. HMG-I(Y) recognizes base-unpaired regions of matrix attachment sequences and its increased expression is directly linked to metastatic breast cancer phenotype
77. alpha1 and alpha2 integrins mediate invasive activity of mouse mammary carcinoma cells through regulation of stromelysin-1 expression
78. On the presence of two new high mobility group-like proteins in HeLa S3 cells
79. On the presence of the chromosomal proteins HMG-I and HMG-Y in rat organs
80. Positive and negative control of human interferon-beta gene expression
81. The matrix-degrading metalloproteinases
82. Combining serial analysis of gene expression and array technologies to identify genes differentially expressed in breast cancer
83. Retinoid-dependent recruitment of a histone H1 displacement activity by retinoic acid receptor
84. Changes in superhelicity are introduced into closed circular DNA by binding of high mobility group protein I/Y
85. Cell adhesion and the integrin-linked kinase regulate the LEF-1 and beta-catenin signaling pathways
86. Differential regulation of a multipromoter gene: Selective 12-O-tetradecanoylphrobol-13-acetate induction of a single transcription start site in the HMG-I/Y gene
87. Sequence and tissue distribution of the integrin alpha 9 subunit, a novel partner of beta 1 that is widely distributed in epithelia and muscle
88. Induction of high mobility group-I(Y) protein by endotoxin and interleukin-1beta in vascular smooth muscle cells. Role in activation of inducible nitric oxide synthase
89. Molecular portraits of human breast tumours
90. Overexpression of the integrin-linked kinase promotes anchorage-independent cell cycle progression
91. Expression of the chromatin regulatory protein HMG-I is an accurate diagnostic marker for neoplastic progression of mammary epithelial cells
92. Elevated high mobility group-I(Y) gene expression is associated with progressive transformation of mouse mammary epithelial cells
93. Structure and function of the HMGI(Y) family of architectural transcription factors
94. The A · T-DNA-binding domain of mammalian high mobility group I chromosomal proteins: A novel peptide motif for recognizing DNA structure
95. Interaction of high mobility group-I(Y) nonhistone proteins with nucleosome core particles
96. Purification and assays for high mobility group HMG-I(Y) protein function
97. Substrate structure influences binding of the non-histone protein HMG-I(Y) to free and nucleosomal DNA
98. Type-1 plasminogen activator inhibitor in human breast carcinomas
99. Adenovirus-mediated suppression of HMGI(Y) protein synthesis as potential therapy of human malignant neoplasias
100. Extracellular matrix proteins protect small cell lung cancer cells against apoptosis: A mechanism for small cell lung cancer growth and drug resistance in vivo
101. In vivo gene expression profile analysis of human breast cancer progression
102. Alpha-9 beta-1 integrin is expressed on human neutrophils and contributes to neutrophil migration through human lung and synovial fibroblast barriers
103. Integrin function in breast carcinoma progression
104. A mammalian high mobility group protein recognizes any stretch of six A-T base pairs in duplex DNA
105. Differentiation state and invasiveness of human breast cancer cell lines
106. Regulation of vimentin gene transcription in human breast cancer cell lines
107. Scatter factor/hepatocyte growth factor and its receptor, the c-Met tyrosine kinase, can mediate a signal exchange between mesenchyme and epithelia during mouse development
108. Modulation of breast cancer progression and differentiation by the gp30/heregulin
109. Deletion of beta 1 integrins in mice results in inner cell mass failure and peri-implantation lethality
110. The stromal proteinase MMP3/stromelysin-1 promotes mammary carcinogenesis
111. Scatter factor is a fibroblast-derived modulator of epithelial cell mobility
112. Targeted disruption of the beta1 integrin gene in a lymphoma cell line greatly reduces metastatic capacity
113. HMGI(Y) and HMGI-C dysregulation: A common occurrence in human tumors
114. Increased expression of high mobility group protein I(Y) in high grade prostate cancer determined by in situ hybridization
115. A retrospective study of high mobility group protein I(Y) as a progression marker for prostate cancer determined by in situ hybridization
116. PTEN gene and integrin signaling in cancer
117. The integrin alpha-9 beta-1 mediates adhesion to activated endothelial cells and transendothelial neutrophil migration through interaction with vascular cell adhesion molecule-1
118. The high mobility group protein HMG-I (Y) is reguired for NF-κB-dependent virus induction of the human interferon-beta gene
119. Virus induction of human IFN beta gene expression requires the assembly of an enhanceosome
120. Epithelial cell plasticity in development and tumor progression
121. Cellextracellular matrix interactions stimulate the AP-1 transcription factor in an integrin-linked kinase- and glycogen synthase kinase 3-dependent manner
122. Regulation of collagenase-3 expression in human breast carcinomas is mediated by stromal-epithelial cell interactions
123. Rho GTPases and signaling networks
124. The adaptor protein Shc couples a class of integrins to the control of cell cycle progression
125. MCF-7 breast cancer cells transfected with protein kinase C-alpha exhibit altered expression of other protein kinase C isoforms and display a more aggressive neoplastic phenotype
126. Reversion of the malignant phenotype of human breast cells in three-dimensional culture and in vivo by integrin blocking antibodies
127. Targeted expression of a dominant-negative FGF receptor mutant in the epidermis of transgenic mice reveals a role for FGF in keratinocyte organization and differentiation
128. The oncogenic properties of the HMG-I gene family
129. HMG-I/Y, a new c-Myc target gene and potential oncogene
130. Integrin-linked protein kinase regulates fibronectin matrix assembly, E-cadherin expression, and tumor/genicity
131. Immunoreactive hepatocyte growth factor is a strong and independent predictor of recurrence and survival in human breast cancer
132. Increased susceptibility to carcinogen-induced mammary tumors in MMTV-Cdc25B transgenic mice
133. Differential effects of the integrins alpha-9 beta-1, alpha-v beta-3, and alpha-v beta-6 on cell proliferative responses to tenascin. Roles of the beta subunit extracellular and cytoplasmic domains